Stock listing
TPEx:6850 Bioptic Inc. (光鼎生技) 股價
Follow Bioptic Inc. into a list and get an email when it puts out news.
Share price · TPEX:6850
$26.00 TWD -0.80 (-3.0%)
Close on Nov 20, 2026
- Day range
- $26.00 – $26.30 TWDNov 20, 2026
- Volume
- 21,003 sharesNov 20, 2026
- Market cap
- $860.3M TWDAt the close on Nov 20, 2026 · price × 33.09M shares outstanding
- 52-week range
- $26.00 – $46.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $397,936 TWDMedian day 6,000 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6850 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.00 | -0.80 | -3.0% | $26.30 | $26.30 | $26.00 | 21,003 | |
| $26.80 | -0.40 | -1.5% | $27.50 | $27.50 | $26.50 | 8,510 | |
| $27.20 | -0.20 | -0.7% | $27.20 | $27.20 | $27.20 | 3,000 | |
| $27.40 | -1.20 | -4.2% | $27.40 | $27.40 | $27.40 | 6,000 | |
| $28.60 | +0.45 | +1.6% | $28.60 | $28.60 | $28.60 | 20 | |
| $28.15 | +0.50 | +1.8% | $28.50 | $28.80 | $28.15 | 7,000 | |
| $27.65 | -0.15 | -0.5% | $28.00 | $28.50 | $27.40 | 11,000 | |
| $27.80 | +0.30 | +1.1% | $27.50 | $28.00 | $27.50 | 10,086 | |
| $27.50 | -0.80 | -2.8% | $28.80 | $28.80 | $27.50 | 14,000 | |
| $28.30 | -1.70 | -5.7% | $29.00 | $29.00 | $28.00 | 10,500 | |
| $30.00 | +0.95 | +3.3% | $29.05 | $30.00 | $29.00 | 22,040 | |
| $29.05 | -0.95 | -3.2% | $29.05 | $29.35 | $29.00 | 8,020 | |
| $30.00 | 0.00 | 0.0% | $30.00 | $30.00 | $30.00 | 0 | |
| $30.00 | 0.00 | 0.0% | $30.00 | $30.00 | $30.00 | 0 | |
| $30.00 | -0.40 | -1.3% | $30.00 | $30.00 | $30.00 | 3,000 | |
| $30.40 | +0.40 | +1.3% | $30.00 | $30.40 | $30.00 | 1,100 | |
| $30.00 | 0.00 | 0.0% | $30.00 | $30.00 | $30.00 | 0 | |
| $30.00 | -0.20 | -0.7% | $30.20 | $30.20 | $30.00 | 41,600 | |
| $30.20 | 0.00 | 0.0% | $30.20 | $30.20 | $30.20 | 0 | |
| $30.20 | +0.20 | +0.7% | $29.05 | $31.55 | $29.00 | 40,209 | |
| $30.00 | 0.00 | 0.0% | $29.80 | $30.30 | $28.90 | 223,261 | |
| $30.00 | -0.10 | -0.3% | $29.75 | $30.30 | $29.75 | 7,243 | |
| $30.10 | -0.90 | -2.9% | $30.70 | $30.70 | $30.10 | 6,000 | |
| $31.00 | +0.30 | +1.0% | $30.70 | $31.00 | $30.70 | 5,030 | |
| $30.70 | -0.60 | -1.9% | $31.00 | $31.00 | $30.70 | 3,001 | |
| $31.30 | +0.10 | +0.3% | $30.70 | $31.50 | $30.50 | 27,252 | |
| $31.20 | +0.20 | +0.6% | $31.00 | $31.20 | $30.80 | 5,003 | |
| $31.00 | 0.00 | 0.0% | $31.00 | $31.30 | $30.90 | 15,151 | |
| $31.00 | -1.00 | -3.1% | $30.90 | $31.20 | $30.90 | 6,136 | |
| $32.00 | +0.85 | +2.7% | $32.00 | $32.50 | $32.00 | 5,525 | |
| $31.15 | +0.15 | +0.5% | $31.00 | $31.15 | $31.00 | 4,000 | |
| $31.00 | 0.00 | 0.0% | $31.60 | $31.60 | $31.00 | 7,000 | |
| $31.00 | -0.30 | -1.0% | $32.00 | $32.00 | $30.90 | 4,760 | |
| $31.30 | 0.00 | 0.0% | $31.30 | $31.30 | $31.30 | 0 | |
| $31.30 | -0.20 | -0.6% | $31.00 | $31.30 | $31.00 | 6,000 | |
| $31.50 | 0.00 | 0.0% | $31.50 | $31.50 | $31.50 | 0 | |
| $31.50 | -0.30 | -0.9% | $31.00 | $31.70 | $31.00 | 6,000 | |
| $31.80 | +0.10 | +0.3% | $31.70 | $31.90 | $31.30 | 34,195 | |
| $31.70 | -0.30 | -0.9% | $31.60 | $32.35 | $31.60 | 18,051 | |
| $32.00 | -0.30 | -0.9% | $32.00 | $32.30 | $31.60 | 20,396 | |
| $32.30 | 0.00 | 0.0% | $32.00 | $32.30 | $32.00 | 12,000 | |
| $32.30 | -0.70 | -2.1% | $32.15 | $32.50 | $32.10 | 15,002 | |
| $33.00 | 0.00 | 0.0% | $32.05 | $33.30 | $32.05 | 6,100 | |
| $33.00 | 0.00 | 0.0% | $33.00 | $33.00 | $33.00 | 0 | |
| $33.00 | +0.60 | +1.9% | $33.00 | $33.00 | $32.40 | 26,000 | |
| $32.40 | -0.90 | -2.7% | $32.80 | $32.80 | $32.05 | 10,237 | |
| $33.30 | +0.30 | +0.9% | $33.30 | $33.30 | $33.30 | 3,000 | |
| $33.00 | +0.90 | +2.8% | $32.10 | $33.00 | $32.10 | 16,510 | |
| $32.10 | -1.50 | -4.5% | $32.10 | $32.10 | $32.10 | 2,000 | |
| $33.60 | 0.00 | 0.0% | $33.60 | $33.60 | $33.60 | 1,000 | |
| $33.60 | 0.00 | 0.0% | $33.60 | $33.60 | $33.60 | 0 | |
| $33.60 | 0.00 | 0.0% | $33.60 | $33.60 | $33.60 | 1,000 | |
| $33.60 | +1.10 | +3.4% | $33.60 | $33.60 | $33.60 | 1,000 | |
| $32.50 | -0.45 | -1.4% | $32.10 | $32.80 | $32.10 | 5,126 | |
| $32.95 | -0.20 | -0.6% | $32.85 | $33.00 | $31.65 | 52,410 | |
| $33.15 | -0.05 | -0.2% | $33.20 | $33.20 | $33.15 | 6,000 | |
| $33.20 | -0.30 | -0.9% | $33.20 | $33.20 | $33.20 | 1,000 | |
| $33.50 | +0.30 | +0.9% | $33.20 | $33.50 | $33.15 | 5,068 | |
| $33.20 | 0.00 | 0.0% | $33.20 | $33.20 | $33.20 | 1,040 | |
| $33.20 | -0.50 | -1.5% | $34.00 | $34.00 | $33.20 | 1,115 | |
| $33.70 | +0.55 | +1.7% | $33.45 | $33.70 | $33.45 | 9,000 | |
| $33.15 | -0.20 | -0.6% | $33.20 | $33.20 | $33.00 | 18,000 |
Splits
3 splits since 2023 · TPEX:6850 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 11-for-10 | Split | |
| 1.1338-for-1 | Split | |
| 11-for-10 | Split |
- Ticker
- TPEx:6850
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TPEx
- Currency
- TWD
Bioptic Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
Price/book 2.0× against a median of 1.3×: 7th lowest of 10 Diagnostics & research services companies shown. balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $743.1M TWD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.0×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bioptic Inc. · TPEX:6850 | US$26.11M | US$22.55M | n/a | n/a | n/a | 2.0× | n/a | 0.2× | n/a |
| MedMira Inc. · TSXV:MIR | US$26.92M | US$27.23M | n/a | 105× | n/a | n/a | −808.2% | n/a | 0.29 |
| BIOQUAL, Inc. · OTC:BIOQ | US$26.83M | US$42.28M | n/a | 1.1× | n/a | 0.8× | −11.0% | 1.0× | -0.01 |
| Ikonisys SA · EURONEXT:ALIKO | US$26.75M | US$31.11M | n/a | 20.4× | n/a | 1.3× | −302.8% | 0.3× | n/a |
| Interpace Biosciences, Inc. · OTC:IDXG | US$26.56M | US$23.63M | 1.2× | 0.6× | 21.0× | 1.1× | 58.1% | 0.0× | -0.33 |
| Microbix Biosystems Inc. · TSX:MBX | US$26.27M | US$25.96M | n/a | 2.4× | n/a | 1.6× | −31.7% | 0.3× | 0.03 |
| genOway SA · EURONEXT:ALGEN | US$25.87M | US$38.95M | 25.4× | 1.7× | 8.7× | 1.1× | 4.4% | 0.7× | n/a |
| Orientbio, Inc. · KRX:002630 | US$25.03M | −US$3.27M | 14.6× | −0.1× | −0.8× | 0.5× | 8.1% | 0.0× | n/a |
| Clever Culture Systems Limited · ASX:CC5 | US$24.62M | US$25.47M | n/a | 8.3× | n/a | 4.9× | −48.4% | 0.4× | n/a |
| CLEO Diagnostics Ltd · ASX:COV | US$24.57M | US$20.44M | n/a | n/a | n/a | 7.4× | n/a | 0.0× | n/a |
| Genesystem Co., Ltd. · KRX:363250 | US$24.54M | US$22.35M | n/a | 29.8× | n/a | 2.8× | n/a | 0.2× | n/a |
| Median of the others | US$26.07M | US$25.72M | 14.6× | 2.4× | 8.7× | 1.3× | −21.3% | 0.3× | 0.01 |
Financials
Annual, in TWD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 202.7M | 228.3M | 231.4M | 179.3M | 123.6M | 92.0M | 62.1M |
| Cost of revenue | 77.4M | 75.5M | 78.8M | 68.9M | 44.5M | 41.3M | 35.4M |
| Gross profit | 125.3M | 152.7M | 152.6M | 110.4M | 79.2M | 50.6M | 26.7M |
| Research and development | 34.8M | 40.5M | 35.5M | 26.7M | 20.5M | 14.8M | 14.0M |
| Selling, general and administrative | 45.3M | 41.1M | 31.8M | 23.8M | 19.0M | 21.5M | 21.1M |
| Operating income | 19.2M | 44.1M | 65.0M | 44.2M | 27.0M | 3.46M | -15.9M |
| Depreciation and amortization | 17.1M | 15.3M | 10.3M | 7.09M | 4.69M | 3.27M | |
| EBITDA | 36.2M | 59.3M | 75.3M | 51.2M | 31.7M | -12.6M | |
| Interest expense | 1.97M | 1.34M | 286.0K | 609.0K | 1.02M | 1.24M | 517.0K |
| Income before tax | 27.6M | 48.4M | 78.3M | 49.7M | 26.4M | 2.14M | -14.9M |
| Income tax | 4.67M | 8.28M | 15.0M | 1.06M | -194.0K | -135.0K | 239.0K |
| Net income | 22.7M | 37.7M | 61.3M | 46.3M | 25.9M | 2.19M | -14.7M |
| Earnings per share, basic | 0.75 | 1.25 | 2.02 | 1.84 | 1.30 | 0.12 | -0.83 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 98.1M | 80.6M | 207.2M | 150.0M | 62.5M | 33.0M | ||
| Short-term investments | 13.5M | 13.5M | 16.0M | |||||
| Receivables | 37.3M | 50.1M | 31.6M | 38.1M | 30.5M | 19.0M | ||
| Inventory | 155.2M | 161.1M | 120.0M | 77.3M | 45.0M | |||
| Current assets | 297.8M | 303.5M | 372.6M | 284.9M | 157.4M | 49.0M | ||
| Goodwill | 27.6M | 27.6M | ||||||
| Total assets | 596.4M | 613.8M | 521.4M | 419.5M | 290.9M | |||
| Accounts payable | 6.16M | 29.9M | 36.6M | 19.9M | 8.51M | 3.85M | ||
| Current liabilities | 47.4M | 77.5M | 84.0M | 42.8M | 27.7M | |||
| Long-term debt | 75.0M | 76.9M | 0 | 0 | ||||
| Total debt | 86.2M | 93.2M | 14.3M | 5.86M | 86.1M | |||
| Total liabilities | 134.7M | 170.6M | 94.1M | 44.7M | 109.7M | |||
| Shareholders' equity | 449.7M | 431.8M | 418.5M | 368.1M | 180.1M | |||
| Shares outstanding | 33.1M | 30.2M | 30.2M | 30.3M | 25.2M | 19.9M | 18.1M | 17.8M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash from operations | 31.1M | -12.7M | 69.5M | 32.4M | 14.6M |
| Capital spending | -6.79M | -114.1M | -6.88M | -7.68M | -1.03M |
| Free cash flow | 24.3M | -126.9M | 62.6M | 24.7M | 11.9M |
| Cash from investing | -2.15M | -159.0M | 2.24M | -7.72M | 952.0K |
| Cash from financing | -12.5M | 45.9M | -14.8M | 62.7M | -1.85M |
| Dividends paid | -5.32M | -24.2M | -11.0M | ||
| Change in cash | 17.5M | -126.6M | 57.2M | 87.5M | 13.5M |
Cap table
Built by 6ix from Bioptic Inc.’s releases
- Common shares
- 33,089,000
- Fully diluted
- 33,089,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 33,089,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 33,089,000 |
Log in to ask 6ix AI your own questions about Bioptic Inc.